ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

LEVULAN KERASTICK
Actinic keratoses
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

LEVULAN KERASTICK Rx

Generic Name and Formulations:
Aminolevulinic acid HCl 20%; topical soln; contains alcohol.

Company:
DUSA Pharmaceuticals, Inc.

Therapeutic Use:

Indications for LEVULAN KERASTICK:

In combination with blue light illumination (BLU-U Blue Light Photodynamic Therapy Illuminator), for the treatment of minimally to moderately thick actinic keratoses (Grade 1 or 2) of the face and scalp.

Adult:

Clean and dry affected area. Apply to either scalp or face but not both simultaneously. One application and one dose of illumination per treatment site per 8-week treatment session. The second visit, for illumination, must take place in the 14–18 hour window following application. Treated lesions not completely resolved after 8 weeks may be treated a second time. Protect treated lesions from sun by wearing head covering. Excessive irritation if applied under occlusion.

Children:

Not recommended.

Contraindications:

Cutaneous photosensitivity at wavelengths of 400–450nm. Porphyria or known allergies to porphyrins.

Warnings/Precautions:

Avoid exposure of photosensitive treatment sites to sunlight or bright indoor light during the period prior to blue light treatment. Avoid applying to eyes, mucous membranes, perilesional skin. Inherited or acquired coagulation defects. Pregnancy (Cat.C). Nursing mothers.

Interactions:

Increased photosensitivity reaction with concomitant photosensitizing agents (eg, griseofulvin, thiazides, sulfonylureas, phenothiazines, sulfonamides, tetracyclines).

Pharmacological Class:

Photosensitizer.

Adverse Reactions:

Cutaneous reactions (eg, stinging, burning, erythema, edema, scaling/crusting, itching, erosion, wheal/flare).

How Supplied:

Single-unit applicators—1, 6

Sign Up for Free e-Newsletters